Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[AIDS therapy with reverse transcriptase inhibitors]

H Mitsuya

    Nihon Rinsho. Japanese Journal of Clinical Medicine
    |September 1, 1993
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4.

    Oncogene·2017
    Same author

    Molecular and cellular analyses of HLA class II-associated susceptibility to autoimmune diseases in the Japanese population.

    Modern rheumatology·2014
    Same author

    PDK1 inhibition is a novel therapeutic target in multiple myeloma.

    British journal of cancer·2013
    Same author

    Effect of translocation defective reverse transcriptase inhibitors on the activity of N348I, a connection subdomain drug resistant HIV-1 reverse transcriptase mutant.

    Cellular and molecular biology (Noisy-le-Grand, France)·2013
    Same author

    The sugar ring conformation of 4'-ethynyl-2-fluoro-2'-deoxyadenosine and its recognition by the polymerase active site of HIV reverse transcriptase.

    Cellular and molecular biology (Noisy-le-Grand, France)·2011
    Same author

    PU.1 induces apoptosis in myeloma cells through direct transactivation of TRAIL.

    Oncogene·2009
    Same journal

    [Development of novel therapeutics for multiple myeloma and improvement of drug lag].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    Same journal

    [Clinical pharmacy services to patients of immunomodulatory drugs].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    Same journal

    [Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    Same journal

    [Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    Same journal

    [The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    Same journal

    [Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    See all related articles